The IASLC Africa Conference on Lung Cancer 2018 is an educational and scientific event which, due to its multidisciplinary nature, will cover all aspects of the management of lung cancers, mesothelioma, thymic and other thoracic malignancies.

ESMO and IASLC are pleased to announce that the 8th edition of the European Lung Cancer Congress (ELCC), will take place 11-14 April, in Geneva, Switzerland.

The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. We invite you to save the date!

Immunotherapy has become very promising treatment modality for patients with lung cancer. Despite these encouraging results, further progress must be made, both in terms of treatment modalities and how to select patients for immunotherapy.

This initial meeting between the FDA, IASLC, industry and investigators is designed to facilitate discussions regarding the standardization of endpoints in neoadjuvant lung cancer trials and to discuss how said endpoints can be validated by comparing novel endpoints to established time to event endpoints.

This IASLC-sponsored meeting is designed to provide information about ongoing clinical trials of the newest therapies for lung cancer.